Risk of intracranial hemorrhage in brain arteriovenous malformations: a systematic review and meta-analysis
- 24 February 2024
- journal article
- review article
- Published by Springer Nature in Journal of Neurology
- Vol. 271 (5) , 2274-2284
Abstract
Background and objective Brain arteriovenous malformations (bAVMs) carry a risk of hemorrhage. We aim to identify factors associated with subsequent hemorrhages. Methods Systematic searches were conducted across the ScienceDirect, Medline, and Cochrane databases. Assessed risk factors included bAVM size, bAVM volume, hemorrhage and seizure presentations, presence of deep venous drainage, deep-seated bAVMs, associated aneurysms, and Spetzler–Martin grade. Subgroup analyses were conducted on prior treatments, hemorrhage presentation, AVM size, and type of management. Results The meta-analysis included 8 cohort studies and 2 trials, with 4,240 participants. Initial hemorrhage presentation (HR 2.41; 95% CI 1.94–2.98; p < 0.001), any deep venous drainage (HR 1.52; 95% CI 1.09–2.13; p = 0.01), and associated aneurysms (HR 1.78; 95% CI 1.41–2.23; p < 0.001) increased secondary hemorrhage risk. Conversely, higher Spetzler–Martin grades (HR 0.77; 95% CI 0.68–0.87; p < 0.001) and larger malformation volumes (HR 0.87; 95% CI 0.76–0.99; p = 0.04) reduced risk. Subgroups showed any deep venous drainage in patients without prior treatment (HR 1.64; 95% CI 1.25–2.15; p < 0.001), bAVM > 3 cm (HR 1.79; 95% CI 1.15–2.78; p = 0.01), and multimodal interventions (HR 1.69; 95% CI 1.12–2.53; p = 0.01) increased risk. The reverse effect was found for patients initially presented without hemorrhage (HR 0.79; 95% CI 0.67–0.93; p = 0.01). Deep bAVM was a risk factor in > 3 cm cases (HR 2.72; 95% CI 1.61–4.59; p < 0.001) and multimodal management (HR 2.77; 95% CI 1.66–4.56; p < 0.001). Kaplan–Meier analysis revealed increased hemorrhage risk for initial hemorrhage presentation, while cumulative survival was higher in intervened patients over 72 months. Conclusion Significant risk factors for bAVMs hemorrhage include initial hemorrhage, any deep venous drainage, and associated aneurysms. Deep venous drainage involvement is a risk factor in cases without prior treatment, those with bAVM > 3 cm, and cases managed with multimodal interventions. Deep bAVM involvement also emerges as a risk factor in cases > 3 cm and those managed with multimodal approaches.Keywords
This publication has 32 references indexed in Scilit:
- Risk factors for hemorrhage of brain arteriovenous malformationCNS Neuroscience & Therapeutics, 2019
- Onyx embolization prior to stereotactic radiosurgery for brain arteriovenous malformations: a single-center treatment algorithmJournal of NeuroInterventional Surgery, 2017
- Linear Accelerator Stereotactic Radiosurgery of Central Nervous System Arteriovenous Malformations: A 15-Year Analysis of Outcome-Related Factors in a Single Tertiary CenterWorld Neurosurgery, 2017
- Epidemiology, genetics, pathophysiology, and prognostic classifications of cerebral arteriovenous malformations2017
- Risk Factors for Subsequent Hemorrhage in Patients with Cerebellar Arteriovenous MalformationsWorld Neurosurgery, 2016
- Brain arteriovenous malformationsNature Reviews Disease Primers, 2015
- Arterial and Venous Aneurysms Associated with Arteriovenous MalformationsWorld Neurosurgery, 2015
- Frequency, risk of hemorrhage and treatment considerations for cerebral arteriovenous malformations with associated aneurysmsActa Neurochirurgica, 2014
- Outcome After Conservative Management or Intervention for Unruptured Brain Arteriovenous MalformationsJAMA, 2014
- Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA): a multicentre, non-blinded, randomised trialThe Lancet, 2014